Among these, germline pathogenic variants of BRCA1, ATM, and PALB2 have been associated with a greater CRC risk, and up to 15% of all CRC present germline or somatic alterations in HR genes [19]. This evidence concerns the gene PALB2 and colorectal carcinoma.